[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2013 Analysis of the Japanese Blood Banking Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape

April 2013 | 426 pages | ID: 29E0E3EA29AEN
Venture Planning Group

US$ 6,160.00 US$ 7,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents a comprehensive analysis of the Japanese blood banking market, including:
  • Major issues pertaining to the Japanese blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese blood banks hospitals and commercial laboratories.
  • Annual placements and installed base estimates for major automated and semi-automated analyzers.
  • Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.
  • Ten-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of current and emerging technologies, and their potential market applications.
  • Product development opportunities for instruments, consumables, and auxiliary products.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Contains 426 pages and 41 tables
A. MAJOR BLOOD TYPING, GROUPING AND INFECTIOUS DISEASE SCREENING TESTS

1. Blood Typing and Grouping Tests
  a. ABO
  b. Antibody Panels
  c. Antibody Screening
  d. Antigen Typing
  e. Antiglobulin Test
  f. Crossmatch
  g. HLA Typing
  h. Rh
  i. Other Blood Groups
2. Infectious Disease Screening Tests
  a. AIDS
    Structure and Composition
    Classification
    Origin of AIDS
    Animal Lentivirus Systems
    Virus Receptors
    HIV Infections in Humans
    Pathogenesis & Pathology
    Overview of Course of HIV Infection
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
    Clinical Findings
    Plasma Viral Load
    Pediactric AIDS
    Neurologic Disease
    Opportunistic Infections
    Protozoa
    Fungi
    Bacteria
    Viruses
    Cancer
    Immunity
    Laboratory Diagnosis
    Virus Isolation
    Serology
    Detection of Viral Nucleic Acid or Antigens
    Epidemiology
    Worldwide Spread of AIDS
    United States
    Routes of Transmission
    Prevention, Treatment, And Control
    Antiviral Drugs
    Vaccines Against HIV
    Transmission of HIV in Blood Products
    HIV Transmission in Transplant and Artificial Insemination Recipients
    Diagnostic Tests
    Enzyme Immunoassay Interpretation
    Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assay (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    DNA Probes
    Overview
    Quantitative Polymerase Chain Reaction
    In Situ PCR
    Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Considerations
  b. Hepatitis
    Hepatitis A
    Hepatitis B
    Structure and Composition
    Replication of Hepatitis B Virus
    Hepatitis C
    Hepatitis D (Delta Hepatitis)
    Hepatitis E
    Hepatitis G
    Hepatitis Virus Infections In Humans
    Pathology
    Clinical Findings
    Laboratory Features
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D
    Hepatitis E
    Virus-Host Immune Reactions
    Epidemiology
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D (Delta Agent)
    Vaccines and Drugs
  c. Cytomegalovirus
    Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
    Diagnostic Tests
    Vaccines and Drugs
  d. Syphilis
    Background
    Diagnostic Tests
    Vaccines and Drugs
  e. West Nile Virus
    Background
    Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
  f. Parvovirus B19
    Microbiology
    Epidemiology
    Clinical Syndromes
    Erythema Infectiosum Slapped (cheek)
    Adult Polyarthropathy
    Transient Aplastic Crisis
    Transient Pancytopenia
    Red Cell Aplasia in the Immunocompromised
    Perinatal Infections
    Diagnosis
    Treatment
  g. Creutzfeldt-Jakob’s Disease
    Background
    Transmission
    Diagnostic Tests
    Major Commercial and Academic Players
    Bayer
    Disease Sciences/BioTec Global
    Imperial College School of Medicine
    Ortho-Clinical Diagnostics
    Pall
    ProMetic Life Sciences
    Proteome Sciences/Idexx
    Q-One Biotech
    Serono
    U.S. Agricultural Research Service
    Drugs
    Vaccines
  h. Malaria
  i. Chagas Disease
  j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
  Background
  Methods
#B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
Abbott
Beckman Coulter/Danaher
Bio-Rad
BioMerieux
Gen-Probe
Grifols
Immucor
Nanosphere
Ortho-Clinical Diagnostics
Roche
Sarstedt
Siemens
Tecan

C. MAJOR IN VITRO DIAGNOSTIC TECHNOLOGIES AND THEIR POTENTIAL APPLICATIONS

1. Molecular Diagnostics
  a. Overview
  b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
  a. Technological Principle
  b. Chemiluminescence
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Electrochemical
  d. Radioimmunoassays (RIA)
  e. Immunoprecipitation
  f. Affinity Chromatography
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
  a. Albumin
  b. Factor VIII
  c. Alpha-2 Antiplasmin
  d. Antithrombin III
  e. Factor IX
  f. Von Willebrand's Factor
  g. Fibrinogen
  h. t-PA
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing

JAPAN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Gen-Probe
Grifols
Immucor
Innogenetics
Ortho-Clinical Diagnostics
Orchid CellMark
Novartis Diagnostics
Proteome Sciences
Roche
Siemens
Tecan

LIST OF TABLES

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: Japan, Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
Japan, Facilities Performing Blood Bank Tests by Market Segment
Japan, Hospital Laboratories Performing Blood Bank Tests By Bed Size
Japan, Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast by Market Segment
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast
Japan, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, Blood Banks Blood Typing and Grouping Test Volume Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast
Japan, Blood Banks Infectious Disease Screening Test Volume Forecast
Japan, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
Japan, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
Japan, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
Japan, All Market Segments Blood Typing And Grouping Reagent Market Forecast by Major Test
Japan, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
Japan, Blood Banks Blood Typing and Grouping Reagent Market By Major Test Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast by Test
Japan, Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
Japan, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
Japan, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast by Test
Japan, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
Japan, HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
Japan, Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier
Japan, CMV Blood Screening Market, Reagent Sales by Major Supplier
Japan, Syphilis Blood Screening Market, Reagent Sales by Major Supplier


More Publications